Peptide Research

Buying BPC-157 in Canada as a research material: what BPC-157 is, why vial size and salt form matter, and how to avoid customs seizures.

Buying GLOW in Canada as a research material: what the blend actually contains, why the milligram total is the only number worth comparing, and how to avoid customs.

CJC-1295 + ipamorelin versus tesamorelin: both are GHRH analogues, but they differ in reconstituted handling, duration, and how many receptor pathways they cover.

Buying GHK-Cu in Canada as a research material: why the copper complex is blue, what that tells you about a batch, and how to avoid customs seizures.

Buying CJC-1295 and ipamorelin in Canada as research materials: the DAC vs no-DAC trap, why the two are blended, and how to avoid customs seizures.

Where to buy MOTS-c in Canada as a research peptide: the two sourcing routes, customs risk, and how to vet a supplier. 10 mg and 40 mg vials, third-party tested.

GHK-Cu is a copper-binding tripeptide studied in skin, tissue and copper-enzyme research. What the copper complex is and how to check what you are buying. Research use only.

Semaglutide works on one receptor. Retatrutide works on three. That is the entire technical difference behind “reta vs sema” — but the two also sit in completely different legal categories, and mixing that up is the most common confusion in this space. Two different categories, not just two molecules Semaglutide is a GLP-1 receptor agonist…

Retatrutide and tirzepatide are the two most requested research peptides in Canada right now, and the difference between them is one receptor. Tirzepatide is a dual agonist — GIP and GLP-1. Retatrutide, commonly shortened to “reta”, engages those same two receptors plus a third: the glucagon receptor. Everything else people debate about the pair follows…

The difference between GLOW and KLOW is exactly one peptide. Both blends are built on the same three-part core — GHK-Cu, BPC-157 and TB-500. KLOW adds a fourth, KPV. Choosing between them is really one question: does that fourth peptide belong in your research or not? The shared core Three peptides appear in both blends,…

NAD+ is not a peptide. It sits in peptide catalogues, gets ordered alongside peptides, and is discussed in the same research conversations — but structurally it belongs to a different class of molecule entirely. That is worth understanding before you order it, because it changes what the purity figure on the COA is actually measuring….

Tesamorelin is a modified version of a hormone your body already makes. The natural molecule, growth hormone releasing hormone, is broken down in circulation within minutes. Tesamorelin is that same sequence with one structural change designed to slow the breakdown down — and that change is essentially the whole point of the compound. The problem…